Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $642.62 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $357.36 | 18 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $95.96 | 5 | $0 (2021) |
| Novo Nordisk Inc | $60.74 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.89 | 2 | $0 (2021) |
| Daiichi Sankyo Inc. | $38.87 | 2 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $25.92 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $18.88 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $439.74 | 22 | AbbVie Inc. ($221.50) |
| 2020 | $102.48 | 5 | AbbVie Inc. ($80.88) |
| 2019 | $74.48 | 4 | AbbVie, Inc. ($54.98) |
| 2017 | $25.92 | 1 | Valeant Pharmaceuticals North America LLC ($25.92) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Gastroenterology | ||||||
| 07/22/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Gastroenterology | ||||||
| 07/15/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/13/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/10/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/08/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/19/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/04/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Gastroenterology | ||||||
| 04/14/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/13/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/23/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Gastroenterology | ||||||
| 02/11/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/28/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 01/26/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: IMMUNOLOGY | ||||||
| 01/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Diabetes | ||||||
| 08/19/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Diabetes | ||||||
| 08/18/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 77 | 804 | $170,520 | $6,228 |
| 2020 | 3 | 64 | 429 | $144,638 | $6,240 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 16 | 16 | $68,520 | $2,225 | 3.2% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 18 | 18 | $38,850 | $2,173 | 5.6% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2021 | 14 | 14 | $53,700 | $1,752 | 3.3% |
| J2704 | Injection, propofol, 10 mg | Office | 2021 | 29 | 756 | $9,450 | $77.26 | 0.8% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 19 | 20 | $46,200 | $2,455 | 5.3% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 18 | 18 | $40,600 | $2,022 | 5.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 12 | 12 | $53,100 | $1,732 | 3.3% |
| J2704 | Injection, propofol, 10 mg | Office | 2020 | 15 | 379 | $4,738 | $31.36 | 0.7% |
About Dr. Samuel Aguhob, MD
Dr. Samuel Aguhob, MD is a Anesthesiology healthcare provider based in Bismarck, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093709065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Aguhob, MD has received a total of $642.62 in payments from pharmaceutical and medical device companies, with $439.74 received in 2021. These payments were reported across 32 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($642.62).
As a Medicare-enrolled provider, Aguhob has provided services to 141 Medicare beneficiaries, totaling 1,233 services with total Medicare billing of $12,468. Data is available for 2 years (2020–2021), covering 8 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Bismarck, ND
- Active Since 09/07/2005
- Last Updated 07/08/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1093709065
Products in Payments
- HUMIRA (Biological) $140.17
- XIFAXAN (Drug) $121.88
- LINZESS (Drug) $98.29
- CREON (Drug) $63.92
- MOTEGRITY (Drug) $44.89
- Ozempic (Drug) $43.87
- INJECTAFER (Drug) $38.87
- Humira (Biological) $36.80
- DIFICID (Drug) $18.88
- RYBELSUS (Drug) $16.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Bismarck
Dr. Patrick Grace, M.d, M.D
Anesthesiology — Payments: $18,938
Dr. Michael Quast, Md, MD
Anesthesiology — Payments: $8,048
Marshall Jones, M.d, M.D
Anesthesiology — Payments: $764.64
Nathan Bro, Md, MD
Anesthesiology — Payments: $133.41
Troy Russon, Md, MD
Anesthesiology — Payments: $133.24
Dr. Nicholas Hoskins, Md, MD
Anesthesiology — Payments: $113.30